We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease (IPSG1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02040714
Recruitment Status : Enrolling by invitation
First Posted : January 20, 2014
Last Update Posted : October 25, 2021
Alberta Children's Hospital
Alfred I. duPont Hospital for Children
Le Bonheur Children's Hospital
Children's Hospital Colorado
Children's Hospital Los Angeles
Children's National Research Institute
Children's Healthcare of Atlanta
Children's Hospital of Philadelphia
Children's Hospital Medical Center, Cincinnati
Columbia University
Connecticut Children's Medical Center
Gillette Children's Specialty Healthcare
Boston Children's Hospital
Johns Hopkins University
Kaiser Permanente
Kasturba Medical College
Montefiore Medical Center
Nationwide Children's Hospital
NYU Langone Health
OrthoCarolina Research Institute, Inc.
University of Sao Paulo General Hospital
Seoul National University Childrens Hospital
Shriners Hospitals for Children
University Hospital Southampton NHS Foundation Trust
Baylor College of Medicine
Universitätsklinikum Hamburg-Eppendorf
Ann & Robert H Lurie Children's Hospital of Chicago
British Columbia Children's Hospital
Children's of Alabama
Hospital Infantil Universitario Niño Jesús, Madrid, Spain
University of Oklahoma
Oregon Health and Science University
Rady Children's Hospital, San Diego
San Jorge Children's Hospital (Puerto Rico)
University College Dublin
Tianjin Children's Hospital
University Hospital Schleswig-Holstein
University of California, San Francisco
University of Haifa
Uppsala University
Information provided by (Responsible Party):
Harry Kim, MD, Texas Scottish Rite Hospital for Children

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : September 2032
Estimated Study Completion Date : September 2032